Edge Therapeutics Inc (EDGE) - Financial and Strategic SWOT Analysis Review

  • ID: 4284600
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4

Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes a range of hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neurological conditions. Its lead pipeline products include EG-1962, a proprietary formulation, which is used to treat aneurysmal subarachnoid hemorrhage, is in Phase 3 clinical trials and EG-1964 is in preclinical stage used to prevent recurrent chronic subdural hematoma. The company’s Precise, a proprietary, programmable, biodegradable polymer-based development platform develops products for the treatment of acute neurological conditions. Edge Therapeutics is headquartered in Berkeley Heights, New Jersey, the US.

Edge Therapeutics Inc Key Recent Developments

Mar 01, 2018: Edge Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 01, 2017: Edge Therapeutics Reports Third Quarter 2017 Financial Results
Oct 06, 2017: Edge Therapeutics to Present at the Neurocritical Care Society 15th Annual Meeting
Sep 19, 2017: Edge Therapeutics Appoints Rosemary A. Crane, Pharmaceutical Industry Leader, to its Board of Directors
Aug 01, 2017: Edge Therapeutics Reports Second Quarter 2017 Financial Results and Continued Operational Progress

This comprehensive SWOT profile of Edge Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Edge Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Edge Therapeutics Inc - Key Information
  • Edge Therapeutics Inc - Overview
  • Edge Therapeutics Inc - Key Employees
  • Edge Therapeutics Inc - Key Employee Biographies
  • Edge Therapeutics Inc - Key Operational Heads
  • Edge Therapeutics Inc - Major Products and Services
  • Edge Therapeutics Inc - History
  • Edge Therapeutics Inc - Company Statement
  • Edge Therapeutics Inc - Locations And Subsidiaries
  • Edge Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Edge Therapeutics Inc - Business Description
  • Edge Therapeutics Inc - Corporate Strategy
  • Edge Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Edge Therapeutics Inc - Strengths
  • Edge Therapeutics Inc - Weaknesses
  • Edge Therapeutics Inc - Opportunities
  • Edge Therapeutics Inc - Threats
  • Edge Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Edge Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Edge Therapeutics Inc, Key Information
  • Edge Therapeutics Inc, Key Ratios
  • Edge Therapeutics Inc, Share Data
  • Edge Therapeutics Inc, Major Products and Services
  • Edge Therapeutics Inc, History
  • Edge Therapeutics Inc, Key Employees
  • Edge Therapeutics Inc, Key Employee Biographies
  • Edge Therapeutics Inc, Key Operational Heads
  • Edge Therapeutics Inc, Other Locations
  • Edge Therapeutics Inc, Subsidiaries
  • Edge Therapeutics Inc, Key Manufacturing facilities
  • Edge Therapeutics Inc, Key Competitors
  • Edge Therapeutics Inc, SWOT Analysis
  • Edge Therapeutics Inc, Ratios based on current share price
  • Edge Therapeutics Inc, Annual Ratios
  • Edge Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Edge Therapeutics Inc, Performance Chart
  • Edge Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown